- Home
- ZCAR vs THAR Comparison
ZCAR vs THAR Comparison
Compare ZCAR & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCAR
- THAR
- Stock Information
- Founded
- ZCAR 2013
- THAR 2017
- Country
- ZCAR India
- THAR United States
- Employees
- ZCAR N/A
- THAR N/A
- Industry
- ZCAR Blank Checks
- THAR Biotechnology: Pharmaceutical Preparations
- Sector
- ZCAR Finance
- THAR Health Care
- Exchange
- ZCAR Nasdaq
- THAR Nasdaq
- Market Cap
- ZCAR 2.9M
- THAR 2.4M
- IPO Year
- ZCAR N/A
- THAR 2022
- Fundamental
- Price
- ZCAR $3.88
- THAR $1.20
- Analyst Decision
- ZCAR
- THAR Strong Buy
- Analyst Count
- ZCAR 0
- THAR 1
- Target Price
- ZCAR N/A
- THAR $17.00
- AVG Volume (30 Days)
- ZCAR 187.2K
- THAR 97.3K
- Earning Date
- ZCAR 02-14-2025
- THAR 05-08-2025
- Dividend Yield
- ZCAR N/A
- THAR N/A
- EPS Growth
- ZCAR N/A
- THAR N/A
- EPS
- ZCAR N/A
- THAR N/A
- Revenue
- ZCAR $9,117,419.00
- THAR N/A
- Revenue This Year
- ZCAR N/A
- THAR N/A
- Revenue Next Year
- ZCAR N/A
- THAR N/A
- P/E Ratio
- ZCAR N/A
- THAR N/A
- Revenue Growth
- ZCAR N/A
- THAR N/A
- 52 Week Low
- ZCAR $2.61
- THAR $0.95
- 52 Week High
- ZCAR $880.00
- THAR $6.45
- Technical
- Relative Strength Index (RSI)
- ZCAR 40.30
- THAR 43.85
- Support Level
- ZCAR $3.03
- THAR $1.05
- Resistance Level
- ZCAR $4.11
- THAR $1.28
- Average True Range (ATR)
- ZCAR 0.70
- THAR 0.11
- MACD
- ZCAR 0.48
- THAR 0.02
- Stochastic Oscillator
- ZCAR 67.20
- THAR 75.58
About ZCAR Zoomcar Holdings Inc.
Zoomcar Holdings Inc is India's largest marketplace for cars on rent. Zoomcar is a leading emerging-market-focused peer-to-peer car-sharing marketplace, with approximately 21,000 vehicles registered through its platform. The Company derives its revenue principally from short-term self-drive rentals and vehicle subscriptions. The self-drive rental business generates the majority of revenue. Geographically The company operates in India, Egypt, Indonesia, Vietnam, and the Philippines, Out of which the majority of revenue is derived from India.
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.